Double Digit Growth of Contract Manufacturing

The global market for biopharmaceutical contract manufacturing is poised for speedy growth over the next few years - about 12 percent per year from 2010 to 2012. The decision to outsource production comes from a desire to generate product quickly and cost-effectively. FW Biokinetics optimization tool, K-TOPS®, together with our best-in-the-industry process expertise, ensures a fast and effective solution to determining the best contract manufacturing facility for your product. By combining knowledge of the desired process and the available equipment and utilities at various contract manufacturing sites, K-TOPS® can provide an analysis of each site.

This valuable information can be used to determine which contract manufacturer to use, and to confirm the expected capacity. It can identify areas where additional equipment (process, process support, and/or utilities) is required in order to achieve the desired production capacity as well as identify the capacity with no equipment changes.

To learn more, check out our K-TOPS® brochure or click here to contact us.